News:   •  Restaurants   •  Library Catalog   •  Library Activities  •  History   •  Facebook / X/Twitter / RSS

Monrovia's Xencor Reports $23.6 Million Net Income for Q1

Monrovia-based Xencor, which develops pharmaceuticals to fight cancer and autoimmune diseases, reported a net income for the first quarter ended March 31, 2022 of $23.6 million, or $.39 per share, compared to a net loss of $2.5 million, or $(.04) per share for the same period in 2021.

- Brad Haugaard

No comments:

Post a Comment